• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
TGA updates montelukast safety information

TGA updates montelukast safety information

Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.


Does montelukast need a warning label?

Does montelukast need a warning label?

The asthma medication is known to cause behavioural and neuropsychiatric disturbance that in rare cases have been linked to suicidal ideation.


Assisting with patient concerns about a prevalent asthma medication

Assisting with patient concerns about a prevalent asthma medication

Dr Kerry Hancock, GP and Chair of the RACGP Respiratory Medicine Specific Interests network, talks to newsGP about prescribing the asthma medication, montelukast.


RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807